- Home
- INTZ vs ANTX Comparison
INTZ vs ANTX Comparison
Compare INTZ & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTZ
- ANTX
- Stock Information
- Founded
- INTZ 1983
- ANTX 2017
- Country
- INTZ United States
- ANTX United States
- Employees
- INTZ N/A
- ANTX N/A
- Industry
- INTZ Computer Communications Equipment
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- INTZ Telecommunications
- ANTX Health Care
- Exchange
- INTZ Nasdaq
- ANTX Nasdaq
- Market Cap
- INTZ 31.8M
- ANTX 34.2M
- IPO Year
- INTZ 2020
- ANTX 2022
- Fundamental
- Price
- INTZ $1.81
- ANTX $1.29
- Analyst Decision
- INTZ Buy
- ANTX Buy
- Analyst Count
- INTZ 2
- ANTX 2
- Target Price
- INTZ $7.00
- ANTX $2.00
- AVG Volume (30 Days)
- INTZ 235.3K
- ANTX 81.8K
- Earning Date
- INTZ 11-07-2025
- ANTX 11-12-2025
- Dividend Yield
- INTZ N/A
- ANTX N/A
- EPS Growth
- INTZ N/A
- ANTX N/A
- EPS
- INTZ N/A
- ANTX N/A
- Revenue
- INTZ $6,828,000.00
- ANTX N/A
- Revenue This Year
- INTZ $36.75
- ANTX N/A
- Revenue Next Year
- INTZ $30.90
- ANTX N/A
- P/E Ratio
- INTZ N/A
- ANTX N/A
- Revenue Growth
- INTZ 25.86
- ANTX N/A
- 52 Week Low
- INTZ $0.35
- ANTX $0.98
- 52 Week High
- INTZ $7.34
- ANTX $1.68
- Technical
- Relative Strength Index (RSI)
- INTZ 51.09
- ANTX 60.03
- Support Level
- INTZ $1.58
- ANTX $1.25
- Resistance Level
- INTZ $1.87
- ANTX $1.37
- Average True Range (ATR)
- INTZ 0.12
- ANTX 0.08
- MACD
- INTZ 0.01
- ANTX -0.00
- Stochastic Oscillator
- INTZ 52.38
- ANTX 39.57
About INTZ Intrusion Inc.
Intrusion Inc is a cybersecurity company based in Plano, Texas. The group offers customers to access its threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol (IP) addresses. The company's product consists of On-Premise Network Protection, Cyber Threat Consulting, Cloud Network Security, and Endpoint Protection. Its solutions are INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. Its end-user customers include the U.S. federal government, state and local government entities, large and diversified conglomerates, and manufacturing entities.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.